GlassScriptPhysician profile
Elise R Wiesner
NPI 1386626497
$10,840.80
in general payments reported to CMS, 2019-2025
55 companies · $1,602 in 2025
The $1,602 reported for 2025 was more than what 91% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,311 · 2020: $809 · 2021: $1,515 · 2022: $1,794 · 2023: $2,153 · 2024: $1,656 · 2025: $1,602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,411.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,257.02 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $1,038.10 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,014.26 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $840.87 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $647.43 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $636.81 | 2019-2024 | Jardiance, Synjardy, Tradjenta |
| Astellas Pharma US INC | $617.64 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $579.22 | 2021-2025 | Vraylar, Ubrelvy |
| Janssen Pharmaceuticals, INC | $540.22 | 2019-2024 | Spravato, Xarelto |
| Amgen INC. | $538.35 | 2019-2025 | Evenity, Prolia, Otezla |
| Takeda Pharmaceuticals U.S.A., INC. | $309.82 | 2019-2025 | Trintellix |
| Merck Sharp & Dohme LLC | $230.08 | 2020-2025 | Gardasil 9, Capvaxive, Belsomra |
| Sanofi-Aventis U.S. LLC | $214.07 | 2019-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $189.60 | 2021-2025 | |
| Idorsia Pharmaceuticals US INC | $178.69 | 2022-2024 | Quviviq |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $174.72 | 2021-2025 | Freestyle Libre 3, Eterna |
| Shield Therapeutics INC | $171.16 | 2025 | |
| Amarin Pharma, INC. | $162.57 | 2019-2022 | |
| Medtronic, INC. | $126.65 | 2022-2025 | Intellis Adaptivestim, Inceptiv |
| Eisai INC. | $116.45 | 2019-2023 | |
| Inspire Medical Systems, INC. | $113.54 | 2023 | Inspire |
| Sunovion Pharmaceuticals INC. | $92.39 | 2021-2022 | |
| Dexcom, INC. | $83.44 | 2022-2024 | Dexcom G6 Transmitter |
| Teva Pharmaceuticals USA, INC. | $80.46 | 2019-2025 | Austedo Xr |
| Sumitomo Pharma America, INC. | $78.88 | 2023-2024 | Gemtesa |
| Xeris Pharmaceuticals, INC. | $70.34 | 2022-2025 | Gvoke Hypopen |
| Nestle Healthcare Nutrition INC. | $66.58 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $60.24 | 2024-2025 | Voquezna |
| Novartis Pharmaceuticals Corporation | $56.88 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $55.02 | 2020-2021 | |
| Exact Sciences Corporation | $49.29 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Cequr Corporation | $46.68 | 2023-2024 | Cequr Simplicity |
| Ibsa Pharma INC. | $37.12 | 2020-2025 | Flector, Licart, Tirosint |
| Biogen, INC. | $36.88 | 2021 | |
| Arbor Pharmaceuticals, INC. | $36.42 | 2021-2022 | |
| Mylan Specialty L.P. | $31.52 | 2023 | Yupelri |
| Currax Pharmaceuticals LLC | $28.82 | 2024 | Contrave, Onzetra Xsail |
| Amneal Pharmaceuticals LLC | $28.10 | 2024 | Unithroid |
| Inogen, INC. | $26.83 | 2022 | |
| Qol Medical, LLC | $23.93 | 2019 | |
| Electromed, INC. | $22.16 | 2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $18.63 | 2019 | |
| Corium, LLC | $17.86 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $16.95 | 2022 | |
| Axsome Therapeutics, INC. | $15.39 | 2025 | Auvelity |
| Genentech USA, INC. | $14.85 | 2020 | |
| Kaleo, INC. | $13.77 | 2022 | |
| Almatica Pharma LLC | $12.50 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.35 | 2019 | |
| Bardy Diagnostics, INC. | $10.25 | 2020 |
5 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elise Wiesner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.